EPL Archives

Pre-Clinical

EPL is the biorepository partner of choice for leading pre-clinical research and development organizations that test biopharmaceuticals, food, dietary supplements, cosmetics and other regulated products.

EPL is the original commercial biorepository and currently serves over 95% of the Fortune 50 pharmaceutical and biotechnology companies.  With hundreds of unique client relationships, many spanning several decades, EPL is a trusted partner that allows our pre-clinical research and development clients to reduce cost, complexity and the risks associated with compliance.

Why Partner with EPL?

  • EPL continues to lead the managed biorepository services industry by creating new performance benchmarks for receiving; indexing; storing; retrieving; value-added processing and shipping or disposal for all types of biomaterials.
  • Our full lifecycle biomaterials management offerings also include innovative services such as Bio-Escrow; Bio-Verification; and Bio-Litigation Support to meet the evolving needs of our global marketplace.
  • EPL employs well-trained people that follow compliant Standard Operating Procedures (SOPs) supported by validated equipment and technology to deliver world-class services.
  • Our services comply with country-specific health regulatory agencies such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMEA) in the European Union.
  • EPL or an EPL affiliate owns and/or maintains control of our special-purpose biorepository facilities, built at a scale that allows us to offer standard and custom environments to meet the exacting requirements of our clients at the lowest possible cost.  We regularly add capacity on demand.
  • We employ Lean Six Sigma practices to reduce defects and waste in everything we do with a goal of exceeding Six Sigma standards in our services delivery practices.

Flexibility to meet your specific needs

We understand that as pre-clinical research and development practices evolve and global compliance issues arise, your needs change.  We also understand the high costs and risks associated with in-house global biomaterials management.  Our services can help you more effectively manage these assets and are available for purchase separately or as an integrated solution.

EPL offers:

  • Managed biorepository services reduce your costs, risks, and complexity with our professional biomaterials management services – from creation to disposal and everything in between, including: logistics; indexing; processing; storage; escrow; verification; and format conversion throughout their lifecycle;
  • Strategic biorepository solutions utilize EPL’s industry leading expertise and experience to: assess risks; create compliant biobanking/storage/archive programs; manage on-site repositories; collaborate on facility designs; get assurance through our independent audits and more; and
  • Consulting and special projects address unique one-time, short-term or ongoing biorepository program needs with a trusted partner that has over three decades of past performance qualifications and an outstanding industry reputation.  A partner who understands the meaning of compliance and how to reduce cost, risk and complexity for companies, universities and governments that support the discovery, pre-clinical, clinical, and manufacturing phases of biopharmaceuticals development.  Examples include facility shutdowns and relocations, master index (MI) reconciliation, temporary or permanent staffing and custom biomaterials tracking systems.

Contact us today to discuss how you can:

  • Maximize the quality and extend the life of your ongoing research, development and manufacturing investments.
  • Reduce pipeline risk by consolidating scattered global biomaterials into highly visible and accessible strategic assets.
  • Reduce your biostorage costs by 25-50% and focus on your core competencies.
  • Improve and manage global regulatory compliance over time.